Author:
Liu P.M.,Feng B.,Shi J.F.,Feng H.J.,Hu Z.J.,Chen Y.H.,Zhang J.P.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangxi Province
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference31 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Cancer statistics, 2012;Siegel;CA: Cancer J Clin,2012
3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol,2011
5. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC;Ramalingam;N Engl J Med,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献